NMS
gene geneOn this page
Summary
NMS (neuromedin S, HGNC:32203) is a protein-coding gene on chromosome 2q11.2, encoding Neuromedin-S (Q5H8A3). Implicated in the regulation of circadian rhythms through autocrine and/or paracrine actions.
This gene encodes a member of the neuromedin family of neuropeptides. The encoded preproprotein is proteolytically processed to generate a biologically active neuropeptide that plays a role in the regulation of circadian rhythm, anorexigenic action, antidiuretic action, cardiovascular function and stimulation of oxytocin and vasopressin release.
Source: NCBI Gene 129521 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_001011717
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32203 |
| Approved symbol | NMS |
| Name | neuromedin S |
| Location | 2q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204640 |
| Ensembl biotype | protein_coding |
| OMIM | 619337 |
| Entrez | 129521 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000376865
RefSeq mRNA: 1 — MANE Select: NM_001011717
NM_001011717
CCDS: CCDS33259
Canonical transcript exons
ENST00000376865 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001471963 | 100483252 | 100483280 |
| ENSE00001471964 | 100482277 | 100482311 |
| ENSE00001471966 | 100481126 | 100481167 |
| ENSE00001471967 | 100480496 | 100480531 |
| ENSE00001471970 | 100479353 | 100479427 |
| ENSE00001471971 | 100477361 | 100477414 |
| ENSE00001471972 | 100477244 | 100477267 |
| ENSE00001471975 | 100473489 | 100473539 |
| ENSE00001471976 | 100472795 | 100472850 |
| ENSE00001471978 | 100470482 | 100470564 |
Expression profiles
Bgee: expression breadth broad, 23 present calls, max score 41.96.
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 41.96 | silver quality |
| hypothalamus | UBERON:0001898 | 41.20 | gold quality |
| right testis | UBERON:0004534 | 37.61 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 36.94 | gold quality |
| left testis | UBERON:0004533 | 36.68 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| testis | UBERON:0000473 | 35.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle of leg | UBERON:0001383 | 33.88 | gold quality |
| gastrocnemius | UBERON:0001388 | 33.69 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| fundus of stomach | UBERON:0001160 | 30.61 | silver quality |
| prefrontal cortex | UBERON:0000451 | 30.49 | silver quality |
| leukocyte | CL:0000738 | 29.87 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| urinary bladder | UBERON:0001255 | 29.38 | silver quality |
| monocyte | CL:0000576 | 29.28 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 28.66 | silver quality |
| frontal cortex | UBERON:0001870 | 28.26 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| blood | UBERON:0000178 | 26.57 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.11 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- NMS is implicated in the regulation of circadian rhythm and feeding behavior (PMID:17870195)
- both NMU receptor and peptide are expressed in human cardiovascular tissues and have shown that NMU-25 and NMS act as potent vasoconstrictors in human vascular beds (PMID:18987052)
- In man, NMS elicits vasoconstriction in isolated saphenous vein with comparable potency with NMU, but significantly reduces maximum contractile response. (PMID:19519756)
- Neuromedin s neurons define a subpopulation of pacemakers that control suprachiasmatic nucleus network synchrony. (PMID:25741729)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Nms | ENSMUSG00000067604 |
| rattus_norvegicus | NMS | ENSRNOG00000038979 |
Protein
Protein identifiers
Neuromedin-S — Q5H8A3 (reviewed: Q5H8A3)
All UniProt accessions (2): Q5H8A3, A0A250SI41
UniProt curated annotations — full annotation on UniProt →
Function. Implicated in the regulation of circadian rhythms through autocrine and/or paracrine actions.
Subcellular location. Secreted.
Similarity. Belongs to the NmU family.
RefSeq proteins (1): NP_001011717* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018070 | Neuromedin-U_amidation-site | PTM |
| IPR043253 | NmS | Family |
UniProt features (8 total): propeptide 4, signal peptide 1, peptide 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7W56 | ELECTRON MICROSCOPY | 2.9 |
| 7W57 | ELECTRON MICROSCOPY | 3.2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5H8A3-F1 | 62.61 | 0.00 |
Antibody-complex structures (SAbDab): 2 — 7W56, 7W57
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 141
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-375276 | Peptide ligand-binding receptors |
| R-HSA-416476 | G alpha (q) signalling events |
| R-HSA-418594 | G alpha (i) signalling events |
MSigDB gene sets: 17 (showing top):
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS, REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS, REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS, chr2q11, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, KINNEY_DNMT1_METHYLATION_TARGETS, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, WP_CIRCADIAN_RHYTHM_GENES, REACTOME_GPCR_LIGAND_BINDING, REACTOME_G_ALPHA_I_SIGNALLING_EVENTS, GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP, GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY, REACTOME_SIGNALING_BY_GPCR, GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP, GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP
GO Biological Process (1): neuropeptide signaling pathway (GO:0007218)
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 2 |
| Class A/1 (Rhodopsin-like receptors) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor signaling pathway | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
478 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NMS | NMUR2 | Q9GZQ4 | 978 |
| NMS | NMUR1 | Q9HB89 | 972 |
| NMS | NMB | P08949 | 620 |
| NMS | GRP | P07491 | 605 |
| NMS | NPS | P0C0P6 | 583 |
| NMS | NPB | Q8NG41 | 545 |
| NMS | PRLH | P81277 | 512 |
| NMS | VIP | P01282 | 512 |
| NMS | PROK2 | Q9HC23 | 499 |
| NMS | NMU | P48645 | 493 |
| NMS | VIPR2 | P41587 | 476 |
| NMS | NTS | P30990 | 469 |
| NMS | NPW | Q8N729 | 464 |
| NMS | TOR2A | Q5JU69 | 432 |
| NMS | NPY | P01303 | 423 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NMS | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (26): COL14A1 (Affinity Capture-MS), CERCAM (Affinity Capture-MS), TCTN1 (Affinity Capture-MS), CACNA2D1 (Affinity Capture-MS), FUT11 (Affinity Capture-MS), NLGN2 (Affinity Capture-MS), GPR98 (Affinity Capture-MS), LRP1B (Affinity Capture-MS), BCHE (Affinity Capture-MS), MANBA (Affinity Capture-MS), FRAS1 (Affinity Capture-MS), WDR47 (Affinity Capture-MS), UBAC1 (Affinity Capture-MS), PCYOX1L (Affinity Capture-MS), CD109 (Affinity Capture-MS)
ESM2 similar proteins: A0A077DF94, D2Z1D6, D6WT67, E2A3M7, E2E4E4, E2E4L2, E7EZ53, F1QQI2, I7C2V3, O42471, O96690, P07808, P08947, P08948, P0DQF0, P0DQY8, P15743, P16043, P16240, P28672, P28673, P33439, P33689, P43443, P51919, P57774, P70074, P81401, P84213, P85527, Q0VBW8, Q0VC44, Q1HA14, Q1HA20, Q29B55, Q4QXT8, Q4V645, Q5H8A1, Q5H8A3, Q91330
Diamond homologs: P12760, P48645, P81872, Q0VBW8, Q5H8A1, Q5H8A2, Q5H8A3, Q9QXK8, P34962, P34964, P34965, P20056, Q1HA14, Q1HA20, Q4QXT8
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| NMS | up-regulates | NMUR1 | binding |
| NMS | up-regulates | NMUR2 | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1303 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:100472866:GTAAT:G | donor_gain | 1.0000 |
| 2:100477359:A:AG | acceptor_gain | 1.0000 |
| 2:100477360:G:GA | acceptor_gain | 1.0000 |
| 2:100477360:GTT:G | acceptor_gain | 1.0000 |
| 2:100477360:GTTTT:G | acceptor_gain | 1.0000 |
| 2:100479350:CA:C | acceptor_loss | 1.0000 |
| 2:100479351:A:AC | acceptor_loss | 1.0000 |
| 2:100479351:A:AG | acceptor_gain | 1.0000 |
| 2:100479352:G:GG | acceptor_gain | 1.0000 |
| 2:100479352:GT:G | acceptor_gain | 1.0000 |
| 2:100479424:GCGA:G | donor_gain | 1.0000 |
| 2:100479425:CGA:C | donor_gain | 1.0000 |
| 2:100479425:CGAGT:C | donor_loss | 1.0000 |
| 2:100479426:GA:G | donor_gain | 1.0000 |
| 2:100479426:GAG:G | donor_gain | 1.0000 |
| 2:100479427:AGT:A | donor_loss | 1.0000 |
| 2:100479428:G:GG | donor_gain | 1.0000 |
| 2:100479428:GTAC:G | donor_loss | 1.0000 |
| 2:100480490:TTGCA:T | acceptor_loss | 1.0000 |
| 2:100480491:TGCA:T | acceptor_loss | 1.0000 |
| 2:100480492:GCA:G | acceptor_loss | 1.0000 |
| 2:100480493:CAG:C | acceptor_loss | 1.0000 |
| 2:100480494:A:AG | acceptor_gain | 1.0000 |
| 2:100480494:A:AT | acceptor_loss | 1.0000 |
| 2:100480494:AG:A | acceptor_gain | 1.0000 |
| 2:100480495:G:A | acceptor_loss | 1.0000 |
| 2:100480495:G:GG | acceptor_gain | 1.0000 |
| 2:100480495:GG:G | acceptor_gain | 1.0000 |
| 2:100480591:G:GT | donor_gain | 1.0000 |
| 2:100480658:GACCC:G | donor_gain | 1.0000 |
AlphaMissense
1001 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:100477367:T:C | F72L | 0.971 |
| 2:100477369:T:A | F72L | 0.971 |
| 2:100477369:T:G | F72L | 0.971 |
| 2:100477361:T:C | F70L | 0.967 |
| 2:100477363:T:A | F70L | 0.967 |
| 2:100477363:T:G | F70L | 0.967 |
| 2:100481162:T:C | F137L | 0.943 |
| 2:100481164:C:A | F137L | 0.943 |
| 2:100481164:C:G | F137L | 0.943 |
| 2:100477263:A:T | K68I | 0.925 |
| 2:100477264:A:C | K68N | 0.924 |
| 2:100477264:A:T | K68N | 0.924 |
| 2:100477362:T:C | F70S | 0.916 |
| 2:100477368:T:C | F72S | 0.890 |
| 2:100481156:T:C | F135L | 0.890 |
| 2:100481158:C:A | F135L | 0.890 |
| 2:100481158:C:G | F135L | 0.890 |
| 2:100482282:G:C | R140S | 0.888 |
| 2:100482282:G:T | R140S | 0.888 |
| 2:100481153:T:C | F134L | 0.876 |
| 2:100481155:T:A | F134L | 0.876 |
| 2:100481155:T:G | F134L | 0.876 |
| 2:100481167:G:C | R138S | 0.867 |
| 2:100481167:G:T | R138S | 0.867 |
| 2:100477362:T:G | F70C | 0.858 |
| 2:100477365:T:C | L71S | 0.852 |
| 2:100477367:T:G | F72V | 0.839 |
| 2:100477368:T:G | F72C | 0.835 |
| 2:100477372:C:A | H73Q | 0.830 |
| 2:100477372:C:G | H73Q | 0.830 |
dbSNP variants (sampled 300 via entrez): RS1000055394 (2:100475166 G>A,C), RS1000174363 (2:100471942 C>A,T), RS1000345900 (2:100477437 C>A), RS1000395533 (2:100480118 G>A), RS1000411578 (2:100483453 A>G,T), RS1000938062 (2:100474073 G>A), RS1000938728 (2:100473815 A>G), RS1001598177 (2:100469411 GA>G,GAA), RS1001662229 (2:100478335 T>C), RS1001681620 (2:100472269 A>G), RS1001778265 (2:100478062 A>G), RS1002048651 (2:100469635 C>G), RS1002222944 (2:100482649 C>G), RS1002435226 (2:100473447 C>A,T), RS1002487824 (2:100473711 CTT>C)
Disease associations
OMIM: gene MIM:619337 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002598_48 | Educational attainment | 8.000000e-06 |
| GCST006922_7 | Regular attendance at a religious group | 3.000000e-11 |
| GCST007155_1 | Household income | 2.000000e-08 |
| GCST009524_101 | Household income (MTAG) | 2.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004784 | self reported educational attainment |
| EFO:0009592 | social interaction measurement |
| EFO:0009695 | household income |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-palmitoylglycerol | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.